EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implementing Massive Parallel Sequencing into Biliary Samples Obtained through Endoscopic Retrograde Cholangiopancreatography for Diagnosing Malignant Bile Duct Strictures

Wonsuk Park iD, Jin Gwack iD, Joonhong Park iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wonsuk Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Se…. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, High-Throughput Nucleotide Sequencing, Bile Duct Neoplasms, Mutation. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund of Biomedical Research Institute, Jeonbuk National University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in radiologic, laboratory, and pathological evaluations, differentiating between benign and malignant bile duct strictures remains a diagnostic challenge. Recent developments in massive parallel sequencing (MPS) have introduced new opportunities for early cancer detection and management, but these techniques have not yet been rigorously applied to biliary samples. We prospectively evaluated the Oncomine Comprehensive Assay (OCA) and the Oncomine Pan-Cancer Cell-Free Assay (OPCCFA) using biliary brush cytology and bile fluid obtained via endoscopic retrograde cholangiopancreatography from patients with bile duct strictures. The diagnostic performance of MPS testing was assessed and compared to the pathological findings of biliary brush cytology and primary tissue. Mutations in TP53, BRAF, CTNNB1, SMAD4, and K-/N-RAS identified in biliary brush cytology samples were also detected in the corresponding bile fluid samples from patients with extrahepatic cholangiocarcinoma. These mutations were also identified in the bile fluid samples, but with variant allele frequencies lower than those in the corresponding biliary brush cytology samples. In control patients diagnosed with gallstones, neither the biliary brush cytology samples nor the bile fluid samples showed any pathogenic mutations classified as tier 1 or 2. Our study represents a prospective investigation into the role of MPS-based molecular testing in evaluating bile duct strictures. MPS-based molecular testing shows promise in identifying actionable genomic alterations, potentially enabling the stratification of patients for targeted chemotherapeutic treatments. Future research should focus on integrating OCA and OPCCFA testing, as well as similar MPS-based assays, into existing surveillance and management protocols for patients with bile duct strictures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangiopancreatography, Endoscopic RetrogradeHigh-Throughput Nucleotide SequencingBile Duct NeoplasmsMutationHumansMaleFemaleMiddle AgedAgedConstriction, PathologicProspective StudiesBileAged, 80 and overAdultCholangiocarcinomaBile Ducts

Stichwörter der Autor:innen

Oncomine Comprehensive AssayOncomine Pan-Cancer Cell-Free Assaybile fluidbiliary brush cytologyendoscopic retrograde cholangiopancreatographyextrahepatic cholangiocarcinomamassive parallel sequencing

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Department of Preventive Medicine, Jeonbuk National University Medical School, Jeonju 54907, Republic of Korea.
  • Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
  • Department of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Republic of Korea.

ORCID-Profile: Wonsuk Park, Jin Gwack, Joonhong Park

Förderung

  • Fund of Biomedical Research Institute
  • Jeonbuk National University Hospital

Zitieren

APA

Park, W., Gwack, J., & Park, J. (2024). Implementing Massive Parallel Sequencing into Biliary Samples Obtained through Endoscopic Retrograde Cholangiopancreatography for Diagnosing Malignant Bile Duct Strictures. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179461

Vancouver

Park W, Gwack J, Park J. Implementing Massive Parallel Sequencing into Biliary Samples Obtained through Endoscopic Retrograde Cholangiopancreatography for Diagnosing Malignant Bile Duct Strictures. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179461

BibTeX
@article{Park2024,
  author = {Park, Wonsuk and Gwack, Jin and Park, Joonhong},
  title = {Implementing Massive Parallel Sequencing into Biliary Samples Obtained through Endoscopic Retrograde Cholangiopancreatography for Diagnosing Malignant Bile Duct Strictures},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179461}
}
Kostenlos starten →